{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:15:53Z","timestamp":1787984153316,"version":"build-2784847793"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21H05278, JP22K15736, JP25H00007"],"award-info":[{"award-number":["JP21H05278, JP22K15736, JP25H00007"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26K10434"],"award-info":[{"award-number":["JP26K10434"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26H02431"],"award-info":[{"award-number":["JP26H02431"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23bm1123046, JP23kk0305024, JP25ek0109811"],"award-info":[{"award-number":["JP23bm1123046, JP23kk0305024, JP25ek0109811"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0425009, JP22bm0804003, JP22ek0109616, JP23bm1423002, JP25wm0625519"],"award-info":[{"award-number":["JP21wm0425009, JP22bm0804003, JP22ek0109616, JP23bm1423002, JP25wm0625519"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UBE Academic Foundation","award":["UBE Academic Foundation"],"award-info":[{"award-number":["UBE Academic Foundation"]}]},{"name":"the Kato Memorial Trust for Nambyo Research","award":["the Kato Memorial Trust for Nambyo Research"],"award-info":[{"award-number":["the Kato Memorial Trust for Nambyo Research"]}]},{"DOI":"10.13039\/100020050","name":"Japan Intractable Diseases Research Foundation","doi-asserted-by":"publisher","award":["2024A04"],"award-info":[{"award-number":["2024A04"]}],"id":[{"id":"10.13039\/100020050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003844","name":"Inamori Foundation","doi-asserted-by":"publisher","award":["Inamori Foundation"],"award-info":[{"award-number":["Inamori Foundation"]}],"id":[{"id":"10.13039\/501100003844","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kanagawa Institute of Industrial Science and Technology (KISTEC)e and Technology","award":["Kanagawa Institute of Industrial Science and Technology (KISTEC)e and Technology"],"award-info":[{"award-number":["Kanagawa Institute of Industrial Science and Technology (KISTEC)e and Technology"]}]},{"DOI":"10.13039\/501100008664","name":"Ono Medical Research Foundation","doi-asserted-by":"publisher","award":["Ono Medical Research Foundation"],"award-info":[{"award-number":["Ono Medical Research Foundation"]}],"id":[{"id":"10.13039\/501100008664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","award":["Nakatomi Foundation"],"award-info":[{"award-number":["Nakatomi Foundation"]}],"id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11604-026-02000-x","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:56:05Z","timestamp":1779098165000},"page":"1576-1587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human iPSC\u2011based translational and reverse translational research for neurodegenerative diseases: emphasis on ALS and key advances"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0022-9529","authenticated-orcid":false,"given":"Satoru","family":"Morimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"16","key":"2000_CR1","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1056\/NEJMc1710379","volume":"377","author":"MJ Tsai","year":"2017","unstructured":"Tsai MJ, Hsu CY, Sheu CC. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(16):1602.","journal-title":"N Engl J Med"},{"issue":"1","key":"2000_CR2","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s42003-025-09168-4","volume":"8","author":"R Nakamura","year":"2025","unstructured":"Nakamura R, Tohnai G, Atsuta N, Matsuda Y, Morimoto S, Ito D, et al. A genome-wide association study identifies the GPM6A locus associated with age at onset in ALS. Commun Biol. 2025;8(1):1720. https:\/\/doi.org\/10.1038\/s42003-025-09168-4.","journal-title":"Commun Biol"},{"issue":"6","key":"2000_CR3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.stem.2023.04.017","volume":"30","author":"S Morimoto","year":"2023","unstructured":"Morimoto S, Takahashi S, Ito D, Dat\u00e9 Y, Okada K, Kato C, et al. Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. Cell Stem Cell. 2023;30(6):766\u2013e7809.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2000_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/jnnp-2024-333690","volume":"96","author":"C Kato","year":"2025","unstructured":"Kato C, Morimoto S, Takahashi S, Namba S, Wang QS, Okada Y, et al. Spinal cord motor neuron phenotypes and polygenic risk scores in sporadic amyotrophic lateral sclerosis: deciphering the disease pathology and therapeutic potential of ropinirole hydrochloride. J Neurol Neurosurg Psychiatry. 2025;96(2):199\u2013201. https:\/\/doi.org\/10.1136\/jnnp-2024-333690.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"2000_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/jnnp-2022-330851","volume":"94","author":"R Nakamura","year":"2023","unstructured":"Nakamura R, Tohnai G, Nakatochi M, Atsuta N, Watanabe H, Ito D, et al. Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients. J Neurol Neurosurg Psychiatry. 2023;94(10):816\u201324. https:\/\/doi.org\/10.1136\/jnnp-2022-330851.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2000_CR6","doi-asserted-by":"publisher","first-page":"102377","DOI":"10.1016\/j.stemcr.2024.11.007","volume":"20","author":"S Setsu","year":"2025","unstructured":"Setsu S, Morimoto S, Nakamura S, Ozawa F, Utami KH, Nishiyama A, et al. Swift induction of human spinal lower motor neurons and robust ALS cell screening via single-cell imaging. Stem Cell Rep. 2025;20(1):102377. https:\/\/doi.org\/10.1016\/j.stemcr.2024.11.007.","journal-title":"Stem Cell Rep"},{"issue":"3","key":"2000_CR7","doi-asserted-by":"publisher","first-page":"104016","DOI":"10.1016\/j.xpro.2025.104016","volume":"6","author":"S Setsu","year":"2025","unstructured":"Setsu S, Morimoto S, Nakamura S, Ozawa F, Okano H. Protocol for the induction of human spinal motor neurons from human induced pluripotent stem cells for studying amyotrophic lateral sclerosis. STAR Protoc. 2025;6(3):104016. https:\/\/doi.org\/10.1016\/j.xpro.2025.104016.","journal-title":"STAR Protoc"},{"key":"2000_CR8","doi-asserted-by":"publisher","unstructured":"Setsu S, Okano H, Morimoto S. Advancements in differentiation of induced pluripotent stem cells into specialized neuronal subtypes. Neural Regen Res. 2025 Oct;30. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-00630.","DOI":"10.4103\/NRR.NRR-D-25-00630"},{"issue":"4","key":"2000_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.stemcr.2016.02.011","volume":"6","author":"N Ichiyanagi","year":"2016","unstructured":"Ichiyanagi N, Fujimori K, Yano M, Ishihara-Fujisaki C, Sone T, Akiyama T, et al. Establishment of in vitro FUS-associated familial amyotrophic lateral sclerosis model using human induced pluripotent stem cells. Stem Cell Rep. 2016;6(4):496\u2013510. https:\/\/doi.org\/10.1016\/j.stemcr.2016.02.011.","journal-title":"Stem Cell Rep"},{"key":"2000_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ebiom.2019.06.013","volume":"45","author":"T Akiyama","year":"2019","unstructured":"Akiyama T, Suzuki N, Ishikawa M, Fujimori K, Sone T, Kawada J, et al. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons. EBioMedicine. 2019;45:362\u201378. https:\/\/doi.org\/10.1016\/j.ebiom.2019.06.013.","journal-title":"EBioMedicine"},{"issue":"6","key":"2000_CR11","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.stemcr.2021.04.021","volume":"16","author":"S Mitsuzawa","year":"2021","unstructured":"Mitsuzawa S, Suzuki N, Akiyama T, Ishikawa M, Sone T, Kawada J, et al. Reduced PHOX2B stability causes axonal growth impairment in motor neurons with TARDBP mutations. Stem Cell Rep. 2021;16(6):1527\u201341. https:\/\/doi.org\/10.1016\/j.stemcr.2021.04.021.","journal-title":"Stem Cell Rep"},{"key":"2000_CR12","doi-asserted-by":"crossref","unstructured":"Imaizumi K, Ideno H, Sato T, Morimoto S, Okano H. Pathogenic mutation of TDP-43 impairs RNA processing in a cell type-specific manner: implications for the pathogenesis of ALS\/FTLD. eNeuro. 2022;9(3).","DOI":"10.1523\/ENEURO.0061-22.2022"},{"issue":"11","key":"2000_CR13","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1093\/brain\/awae224","volume":"147","author":"K Okada","year":"2024","unstructured":"Okada K, Ito D, Morimoto S, Kato C, Oguma Y, Warita H, et al. Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis. Brain. 2024;147(11):3933\u201348. https:\/\/doi.org\/10.1093\/brain\/awae224.","journal-title":"Brain"},{"issue":"10","key":"2000_CR14","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/s41591-018-0140-5","volume":"24","author":"K Fujimori","year":"2018","unstructured":"Fujimori K, Ishikawa M, Otomo A, Atsuta N, Nakamura R, Akiyama T, et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med. 2018;24(10):1579\u201389. https:\/\/doi.org\/10.1038\/s41591-018-0140-5.","journal-title":"Nat Med"},{"issue":"2","key":"2000_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.tips.2019.12.002","volume":"41","author":"H Okano","year":"2020","unstructured":"Okano H, Yasuda D, Fujimori K, Morimoto S, Takahashi S. Ropinirole, a new ALS drug candidate developed using iPSCs. Trends Pharmacol Sci. 2020;41(2):99\u2013109.","journal-title":"Trends Pharmacol Sci"},{"issue":"17","key":"2000_CR16","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1038\/s44318-025-00506-0","volume":"44","author":"Y Watanabe","year":"2025","unstructured":"Watanabe Y, Suzuki N, Nakagawa T, Hosogane M, Akiyama T, Kageyama N, et al. ALS-associated RNA-binding proteins promote UNC13A transcription through REST downregulation. EMBO J. 2025;44(17):4745\u201371. https:\/\/doi.org\/10.1038\/s44318-025-00506-0.","journal-title":"EMBO J"},{"issue":"8652","key":"2000_CR17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(89)90146-3","volume":"1","author":"R Kapoon","year":"1989","unstructured":"Kapoon R, Pirtosek Z, Frankel JP, Stern GM, Lees AJ, Bottomley JM, et al. Treatment of Parkinson\u2019s disease with novel dopamine D2 agonist SK&F 101468. Lancet. 1989;1(8652):1445\u20136.","journal-title":"Lancet"},{"issue":"8","key":"2000_CR18","doi-asserted-by":"publisher","first-page":"e70183","DOI":"10.1111\/jnc.70183","volume":"169","author":"H Asano","year":"2025","unstructured":"Asano H, Kawaguchi T, Kato C, Morimoto S, Yano M, Minaguchi M, et al. Ropinirole functions through a dopamine receptor D2-independent mechanism to ameliorate amyotrophic lateral sclerosis phenotypes in TARDBP-Mutant iPSC-derived motor neurons. J Neurochem. 2025;169(8):e70183. https:\/\/doi.org\/10.1111\/jnc.70183.","journal-title":"J Neurochem"},{"issue":"2","key":"2000_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","volume":"29","author":"H Okano","year":"2022","unstructured":"Okano H, Morimoto S. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. Cell Stem Cell. 2022;29(2):189\u2013208.","journal-title":"Cell Stem Cell"},{"key":"2000_CR20","doi-asserted-by":"publisher","unstructured":"Morimoto S, Takahashi S, Fukushima K, Saya H, Suzuki N, Aoki M, et al. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis\u2013Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I\/IIa clinical trial (ROPALS trial). Regen Ther. 2019. https:\/\/doi.org\/10.1016\/j.reth.2019.07.002.","DOI":"10.1016\/j.reth.2019.07.002"},{"issue":"5","key":"2000_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/jnc.16005","volume":"167","author":"H Okano","year":"2023","unstructured":"Okano H, Morimoto S, Kato C, Nakahara J, Takahashi S. Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis. J Neurochem. 2023;167(5):603\u201314. https:\/\/doi.org\/10.1111\/jnc.16005.","journal-title":"J Neurochem"},{"issue":"2","key":"2000_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/jamaneurol.2020.4300","volume":"78","author":"BJ Wainger","year":"2021","unstructured":"Wainger BJ, Macklin EA, Vucic S, McIlduff CE, Paganoni S, Maragakis NJ, et al. Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial. JAMA Neurol. 2021;78(2):186\u201396. https:\/\/doi.org\/10.1001\/jamaneurol.2020.4300.","journal-title":"JAMA Neurol"},{"issue":"3","key":"2000_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. 2023;22(3):185\u2013212. https:\/\/doi.org\/10.1038\/s41573-022-00612-2. PubMed PMID: 36543887.","journal-title":"Nat Rev Drug Discov"},{"key":"2000_CR24","doi-asserted-by":"publisher","first-page":"101707","DOI":"10.1016\/j.eclinm.2022.101707","volume":"53","author":"K Imamura","year":"2022","unstructured":"Imamura K, Izumi Y, Nagai M, Nishiyama K, Watanabe Y, Hanajima R, et al. Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): a multicentre, open-label, dose-escalation phase 1 trial. EClinicalMedicine. 2022;53:101707. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101707.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2000_CR25","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/s42003-025-08947-3","volume":"8","author":"T Tanaka","year":"2025","unstructured":"Tanaka T, Morimoto S, Ito K, Yasutake K, Kato C, Shinozaki M, et al. Cerebrospinal fluid extracellular vesicle-derived miR-9-3p in spinal cord injury with neuroprotective implications and biomarker development. Commun Biol. 2025;8(1):1498. https:\/\/doi.org\/10.1038\/s42003-025-08947-3.","journal-title":"Commun Biol"},{"issue":"1","key":"2000_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s41232-024-00346-1","volume":"44","author":"C Kato","year":"2024","unstructured":"Kato C, Ueda K, Morimoto S, Takahashi S, Nakamura S, Ozawa F, et al. Proteomic insights into extracellular vesicles in ALS for therapeutic potential of Ropinirole and biomarker discovery. Inflamm Regen. 2024;44(1):32. https:\/\/doi.org\/10.1186\/s41232-024-00346-1.","journal-title":"Inflamm Regen"},{"key":"2000_CR27","doi-asserted-by":"publisher","unstructured":"Takahashi K, Kato C, Ueda K, Nakamura S, Ozawa F, Moritoki N, et al. Diagnostic potential of cryptic exon-derived peptides in serum extracellular vesicles for sporadic amyotrophic lateral sclerosis. Inflamm Regen. 2026. https:\/\/doi.org\/10.1186\/s41232-026-00404-w.","DOI":"10.1186\/s41232-026-00404-w"},{"key":"2000_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neures.2019.10.006","volume":"158","author":"M Sho","year":"2020","unstructured":"Sho M, Ichiyanagi N, Imaizumi K, Ishikawa M, Morimoto S, Watanabe H, et al. A combinational treatment of carotenoids decreases A\u03b2 secretion in human neurons via \u03b2-secretase inhibition. Neurosci Res. 2020;158:47\u201355. https:\/\/doi.org\/10.1016\/j.neures.2019.10.006.","journal-title":"Neurosci Res"},{"issue":"9","key":"2000_CR29","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.stemcr.2023.08.002","volume":"18","author":"H Watanabe","year":"2023","unstructured":"Watanabe H, Murakami R, Tsumagari K, Morimoto S, Hashimoto T, Imaizumi K, et al. Astrocytic APOE4 genotype-mediated negative impacts on synaptic architecture in human pluripotent stem cell model. Stem Cell Rep. 2023;18(9):1854\u201369.","journal-title":"Stem Cell Rep"},{"issue":"10","key":"2000_CR30","doi-asserted-by":"publisher","first-page":"105140","DOI":"10.1016\/j.isci.2022.105140","volume":"25","author":"H Ideno","year":"2022","unstructured":"Ideno H, Imaizumi K, Shimada H, Sanosaka T, Nemoto A, Kohyama J, et al. Human PSCs determine the competency of cerebral organoid differentiation via FGF signaling and epigenetic mechanisms. iScience. 2022;25(10):105140. https:\/\/doi.org\/10.1016\/j.isci.2022.105140.","journal-title":"iScience"},{"issue":"9","key":"2000_CR31","doi-asserted-by":"publisher","first-page":"100289","DOI":"10.1016\/j.crmeth.2022.100289","volume":"2","author":"H Shimada","year":"2022","unstructured":"Shimada H, Sato Y, Sasaki T, Shimozawa A, Imaizumi K, Shindo T, et al. A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transfer. Cell Rep Methods. 2022;2(9):100289. https:\/\/doi.org\/10.1016\/j.crmeth.2022.100289.","journal-title":"Cell Rep methods"},{"issue":"1","key":"2000_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-021-00473-0","volume":"16","author":"C Claes","year":"2021","unstructured":"Claes C, Danhash EP, Hasselmann J, Chadarevian JP, Shabestari SK, England WE, et al. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u2019s disease. Mol Neurodegener. 2021;16(1):50. https:\/\/doi.org\/10.1186\/s13024-021-00473-0.","journal-title":"Mol Neurodegener"},{"issue":"8","key":"2000_CR33","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.3390\/ijms26083774","volume":"26","author":"X Guo","year":"2025","unstructured":"Guo X, Wang X, Wang J, Ma M, Ren Q. Current development of iPSC-based modeling in neurodegenerative diseases. Int J Mol Sci. 2025;26(8):3774. https:\/\/doi.org\/10.3390\/ijms26083774.","journal-title":"Int J Mol Sci"},{"issue":"8064","key":"2000_CR34","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","volume":"641","author":"N Sawamoto","year":"2025","unstructured":"Sawamoto N, Doi D, Nakanishi E, Sawamura M, Kikuchi T, Yamakado H, et al. Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease. Nature. 2025;641(8064):971\u20137. https:\/\/doi.org\/10.1038\/s41586-025-08700-0.","journal-title":"Nature"},{"issue":"8064","key":"2000_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/d41586-025-00688-x","volume":"641","author":"H Okano","year":"2025","unstructured":"Okano H. Clinical trials test the safety of stem-cell therapy for Parkinson\u2019s disease. Nature. 2025;641(8064):853\u20134. https:\/\/doi.org\/10.1038\/d41586-025-00688-x.","journal-title":"Nature"},{"issue":"2","key":"2000_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"HD iPSC Consortium","year":"2012","unstructured":"HD iPSC Consortium. Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell. 2012;11(2):264\u201378.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2000_CR37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s42003-021-02304-w","volume":"4","author":"S Oura","year":"2021","unstructured":"Oura S, Noda T, Morimura N, Hitoshi S, Nishimasu H, Nagai Y, et al. Precise CAG repeat contraction in a Huntington\u2019s disease mouse model is enabled by gene editing with SpCas9-NG. Commun Biol. 2021;4(1):771. https:\/\/doi.org\/10.1038\/s42003-021-02304-w.","journal-title":"Commun Biol"},{"issue":"1","key":"2000_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00401-024-02734-w","volume":"147","author":"N Leventoux","year":"2024","unstructured":"Leventoux N, Morimoto S, Ishikawa M, Nakamura S, Ozawa F, Kobayashi R, et al. Aberrant CHCHD2-associated mitochondriopathy in Kii ALS\/PDC astrocytes. Acta Neuropathol. 2024;147(1):84. https:\/\/doi.org\/10.1007\/s00401-024-02734-w.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2000_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41593-022-01207-1","volume":"26","author":"KH Morelli","year":"2023","unstructured":"Morelli KH, Wu Q, Gosztyla ML, Liu H, Yao M, Zhang C, et al. An RNA-targeting CRISPR\u2013Cas13d system alleviates disease-related phenotypes in Huntington\u2019s disease models. Nat Neurosci. 2023;26(1):27\u201338. https:\/\/doi.org\/10.1038\/s41593-022-01207-1.","journal-title":"Nat Neurosci"},{"issue":"1","key":"2000_CR40","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.1038\/s41467-022-33332-7","volume":"13","author":"KE Meijboom","year":"2022","unstructured":"Meijboom KE, Abdallah A, Fordham NP, Nagase H, Rodriguez T, Kraus C, et al. CRISPR\/Cas9-mediated excision of ALS\/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro. Nat Commun. 2022;13(1):6286. https:\/\/doi.org\/10.1038\/s41467-022-33332-7.","journal-title":"Nat Commun"},{"issue":"5","key":"2000_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41434-022-00375-w","volume":"30","author":"YA Chen","year":"2023","unstructured":"Chen YA, Kankel MW, Hana S, Lau SK, Zavodszky MI, McKissick O, et al. In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model. Gene Ther. 2023;30(5):443\u201354. https:\/\/doi.org\/10.1038\/s41434-022-00375-w.","journal-title":"Gene Ther"},{"issue":"8054","key":"2000_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-024-08487-6","volume":"639","author":"SP Pa\u0219ca","year":"2025","unstructured":"Pa\u0219ca SP, Arlotta P, Bateup HS, Camp JG, Cappello S, Gage FH, et al. A framework for neural organoids, assembloids and transplantation studies. Nature. 2025;639(8054):315\u201320. https:\/\/doi.org\/10.1038\/s41586-024-08487-6.","journal-title":"Nature"},{"issue":"9","key":"2000_CR43","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41591-02201983-0","volume":"28","author":"H Okano","year":"2022","unstructured":"Okano H. A combined stem-cell-gene therapy strategy for ALS. Nat Med. 2022;28(9):1751\u20132. https:\/\/doi.org\/10.1038\/s41591-02201983-0.","journal-title":"Nat Med"},{"key":"2000_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1756-6606-7-22","volume":"7","author":"H Okano","year":"2014","unstructured":"Okano H, Yamanaka S. iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain. 2014;7:22. https:\/\/doi.org\/10.1186\/1756-6606-7-22.","journal-title":"Mol Brain"},{"key":"2000_CR45","doi-asserted-by":"publisher","unstructured":"Nikolakopoulou AM, Wang Y, Ma Q, Sagare AP, Montagne A, Huuskonen MT, et al. Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. J Exp Med. 2021;218(4).  https:\/\/doi.org\/10.1084\/jem.20202207.","DOI":"10.1084\/jem.20202207"},{"issue":"1","key":"2000_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Di Storck","year":"2015","unstructured":"Storck SE, Meister S, Nahrath J, Mei\u00dfner JN, Schubert N, Di Spiezio A, et al. Endothelial LRP1 transportsamyloid-\u03b21\u201342 across the blood-brain barrier. J Clin Invest. 2015;126(1):123\u201336.  https:\/\/doi.org\/10.1172\/JCI81108.","journal-title":"J Clin Invest"},{"issue":"1","key":"2000_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","volume":"13","author":"Q Ma","year":"2018","unstructured":"Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, et al. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent apolipoprotein E isoform-specific mechanism. MolNeurodegener. 2018;13(1):57.  https:\/\/doi.org\/10.1186\/s13024-018-0286-0.","journal-title":"MolNeurodegener"},{"issue":"1","key":"2000_CR48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41576-023-00637-2","volume":"25","author":"L Kachuri","year":"2024","unstructured":"Kachuri L, Chatterjee N, Hirbo J, Schaid DJ, Martin I, Kullo IJ, et al. Principles and methods for transferringpolygenic risk scores across global populations. Nat Rev Genet. 2024;25(1):8\u201325.  https:\/\/doi.org\/10.1038\/s41576-023-00637-2.","journal-title":"Nat Rev Genet"},{"key":"2000_CR49","doi-asserted-by":"publisher","unstructured":"Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, et al. The Src\/c-Abl pathway is a potentialtherapeutic target in amyotrophic lateral sclerosis. Sci Transl Med. 2017;9(391).  https:\/\/doi.org\/10.1126\/scitranslmed.aaf3962.","DOI":"10.1126\/scitranslmed.aaf3962"},{"issue":"1","key":"2000_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med. 2023;388(1):9\u201321.  https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"issue":"4","key":"2000_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimer\u2019s Dement. 2011;7(4):367\u201385.  https:\/\/doi.org\/10.1016\/j.jalz.2011.05.2351.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"2000_CR52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12987-024-00580-2","volume":"21","author":"Y Ding","year":"2024","unstructured":"Ding Y, Palecek SP, Shusta EV. iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta. Fluids Barriers CNS. 2024;21(1):79.  https:\/\/doi.org\/10.1186\/s12987-024-00580-2.","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"2000_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"J Cummings","year":"2023","unstructured":"Cummings J, Apostolova L, Rabinovici GD, Atri A, Aisen P, Greenberg S, et al. Lecanemab: Appropriate Use Recommendations. J Prev Alzheimers Dis. 2023;10(3):362\u201377.  https:\/\/doi.org\/10.14283\/jpad.2023.30.","journal-title":"J Prev Alzheimers Dis"},{"issue":"12","key":"2000_CR54","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.3390\/cells9122680","volume":"9","author":"N Leventoux","year":"2020","unstructured":"Leventoux N, Morimoto S, Imaizumi K, Sato Y, Takahashi S, Mashima K, et al. Human Astrocytes Model Derived from Induced Pluripotent Stem Cells. Cells. 2020;9(12):2680.  https:\/\/doi.org\/10.3390\/cells9122680.","journal-title":"Cells"},{"key":"2000_CR55","doi-asserted-by":"publisher","unstructured":"Matsuo K, Nagamatsu J, Nagata K, Umeda R, Shiota T, Morimoto S, et al. Establishment of a novelamyotrophic lateral sclerosis patient (TARDBPN345K\/+)-derived brain microvascular endothelial cell model reveals defective Wnt\/\u03b2-catenin signaling: investigating diffusion barrier dysfunction and immune cell interaction. Front Cell Dev Biol. 2024;12.  https:\/\/doi.org\/10.3389\/fcell.2024.1357204.","DOI":"10.3389\/fcell.2024.1357204"},{"key":"2000_CR56","doi-asserted-by":"publisher","unstructured":"Maz\u00f3n M, V\u00e1zquez Costa JF, Ten-Esteve A, Mart\u00ed-Bonmat\u00ed L. Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis. Front Neuro sci. 2018;12.  https:\/\/doi.org\/10.3389\/fnins.2018.00784.","DOI":"10.3389\/fnins.2018.00784"},{"issue":"1","key":"2000_CR57","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1038\/s41598-020-62049-0","volume":"10","author":"SH Baek","year":"2020","unstructured":"Baek SH, Park J, Kim YH, Seok HY, Oh KW, Kim HJ, et al. Usefulness of diff usion tensor imaging fi ndings asbiomarkers for amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):5199.  https:\/\/doi.org\/10.1038\/s41598-020-62049-0.","journal-title":"Sci Rep"},{"issue":"1","key":"2000_CR58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s43856-023-00318-5","volume":"3","author":"PK Pisharady","year":"2023","unstructured":"Pisharady PK, Eberly LE, Adanyeguh IM, Manousakis G, Guliani G, Walk D, et al. Multimodal MRI improves diagnostic accuracy and sensitivity to longitudinal change in amyotrophic lateral sclerosis. Commun Med. 2023;3(1):84.  https:\/\/doi.org\/10.1038\/s43856-023-00318-5.","journal-title":"Commun Med"},{"issue":"7","key":"2000_CR59","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/acn3.212","volume":"2","author":"RAL Menke","year":"2015","unstructured":"Menke RAL, Gray E, Lu C, Kuhle J, Talbot K, Malaspina A, et al. scpCSF\/scp neurofilament light chain reflects corticospinal tract degeneration in scpALS\/scp. Ann Clin Transl Neurol. 2015;2(7):748\u201355.  https:\/\/doi.org\/10.1002\/acn3.212.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"2000_CR60","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3390\/ijms24031911","volume":"24","author":"A Behler","year":"2023","unstructured":"Behler A, M\u00fcller HP, Ludolph AC, Kassubek J. Diffusion tensor imaging in amyotrophic lateral sclerosis: machine learning for biomarker development. Int J Mol Sci. 2023;24(3):1911. https:\/\/doi.org\/10.3390\/ijms24031911.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2000_CR61","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.2214\/AJR.14.13459","volume":"204","author":"AD Schweitzer","year":"2015","unstructured":"Schweitzer AD, Liu T, Gupta A, Zheng K, Seedial S, Shtilbans A, et al. Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. AJR Am J Roentgenol. 2015;204(5):1086\u201392. https:\/\/doi.org\/10.2214\/AJR.14.13459 PubMed PMID: 25905946.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2000_CR62","doi-asserted-by":"publisher","first-page":"17593","DOI":"10.1038\/s41598-019-53009-4","volume":"9","author":"JU Blicher","year":"2019","unstructured":"Blicher JU, Eskildsen SF, St\u00e6rmose TG, M\u00f8ller AT, Figlewski K, Near J. Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T. Sci Rep. 2019;9(1):17593.  https:\/\/doi.org\/10.1038\/s41598-019-53009-4.","journal-title":"Sci Rep"},{"issue":"12","key":"2000_CR63","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/WNR.0b013e328363148","volume":"24","author":"F Zhou","year":"2013","unstructured":"Zhou F, Gong H, Li F, Zhuang Y, Zang Y, Xu R, et al. Altered motor network functional connectivity in amyotrophic lateral sclerosis: a resting-state functional magnetic resonance imaging study. Neuro Rep. 2013;24(12):657\u201362. https:\/\/doi.org\/10.1097\/WNR.0b013e328363148c PubMed PMID: 23839257.","journal-title":"Neuro Rep"},{"key":"2000_CR64","doi-asserted-by":"publisher","unstructured":"Akiyama T, Suzuki N, Ishikawa M, Fujimori K, Sone T, Kawada J, et al. Aberrant axon branching via Fos-Bdysregulation in FUS-ALS motor neurons. EBioMedicine. 2019;45.  https:\/\/doi.org\/10.1016\/j.ebiom.2019.06.013.","DOI":"10.1016\/j.ebiom.2019.06.013"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02000-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02000-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02000-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:17:26Z","timestamp":1787980646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-026-02000-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1007\/s11604-026-02000-x","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HO is a co-founder and CSO of K Pharma, Inc. and received personal fees from Sanbio Co. Ltd. outside the submitted work. In addition, HO has a patent on a therapeutic agent for amyotrophic lateral sclerosis and composition for treatment licensed to K Pharma, Inc. The other authors have declared that no conflict of interest exists.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}